Lv41
554 积分 2023-07-12 加入
RET Inhibitors in RET Fusion-Positive Lung Cancers: Past, Present, and Future
2小时前
已完结
Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies
2小时前
已完结
Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death—Results from the Norwegian Prostate Cancer Consortium
1个月前
已完结
Drug resistance profiles of mutations in the RET kinase domain
1个月前
已完结
The L730V/I RET roof mutations display different activities toward pralsetinib and selpercatinib
1个月前
已完结
Predicting EGFR Mutation Status in Non–Small Cell Lung Cancer Using Artificial Intelligence: A Systematic Review and Meta-Analysis
1个月前
已完结
PP01.34 Next Generation Sequencing Evaluation to Detect Circulating Tumor DNA and Minimal Residual Disease in Limited Stage Small Cell Lung Cancer
1个月前
已关闭
A meta-analysis of circulating tumor DNA as a survival indicator in small cell lung cancer patients
1个月前
已完结
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions
1个月前
已完结
Design and Rationale for a Phase II/III, Randomized, Double-Blind, Placebo-Controlled Study of Sugemalimab as Consolidation Therapy in Patients With Limited-Stage Small-Cell Lung Cancer Who Have Not Progressed Following Concurrent or Sequential Chemoradiotherapy: The SURPASS Study
1个月前
已完结
皖公网安备34019202002308
